AtriCure Reports Fourth Quarter and Full Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Piper Jaffray Reiterates Outperform as AtriCure (ATRC) Reports Strong 4Q Results
February 24, 2016 10:10 AM ESTPiper Jaffray maintained an Overweight rating on AtriCure Inc. (NASDAQ: ATRC), and cut the price target to $22.00 (from $25.00), following the company's 4Q earnings report. ATRC reported revenues that came in-line with it's Januarys pre-announcement. The loss per share was a little less than expected, due to lower-than-expected R&D expenses.
Analyst... More
AtriCure (ATRC) Reports In-Line Q4 EPS
February 23, 2016 4:40 PM ESTAtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.36), in-line with the analyst estimate of ($0.36). Revenue for the quarter came in at $35.9 million versus the consensus estimate of $35.89 million.
We are pleased to report strong 2015 results, positioning us well in 2016 as we continue to execute on... More
